Cytosorbents Corporation (CTSO) vs IRIDEX Corporation (IRIX)
Cytosorbents Corporation and IRIDEX Corporation are both Medical Devices companies. Cytosorbents Corporation is the larger, with a market value of $13.6M against $11.1M — 1.2× the size. IRIDEX Corporation grew revenue faster over the last twelve months: 3.68% against 3.07%. IRIDEX Corporation has the higher net margin (−6.88% vs −48.9%) and the higher return on invested capital (−63.1% vs −66.9%). Across the 17 metrics below, IRIDEX Corporation leads on 13 and Cytosorbents Corporation on 4.
Valuation
Profitability
| Metric | CTSO | IRIX | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.61% | 35.92% | 56.01% |
| Operating margin | (34.74%) | (5.39%) | (15.03%) |
| Net margin | (48.94%) | (6.88%) | (20.40%) |
| Free cash flow margin | (25.32%) | (3.88%) | (7.24%) |
| Return on equity | (336.17%) | 308.17% | (15.32%) |
| Return on assets | (42.38%) | (12.06%) | (19.72%) |
| Return on invested capital | (66.90%) | (63.07%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack